156 related articles for article (PubMed ID: 12227897)
41. Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells.
Gonzalez A; Cos S; Martinez-Campa C; Alonso-Gonzalez C; Sanchez-Mateos S; Mediavilla MD; Sanchez-Barcelo EJ
J Pineal Res; 2008 Aug; 45(1):86-92. PubMed ID: 18298468
[TBL] [Abstract][Full Text] [Related]
42. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
[TBL] [Abstract][Full Text] [Related]
43. Effects of Org OD14 (Livial) and its metabolites on 17 beta-hydroxysteroid dehydrogenase activity in hormone-dependent MCF-7 and T-47D breast cancer cells.
Chetrite GS; Kloosterboer HJ; Philippe JC; Pasqualini JR
Anticancer Res; 1999; 19(1A):261-7. PubMed ID: 10226552
[TBL] [Abstract][Full Text] [Related]
44. Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol, and promegestone (R-5020).
Nguyen BL; Chetrite G; Pasqualini JR
Breast Cancer Res Treat; 1995 May; 34(2):139-46. PubMed ID: 7647331
[TBL] [Abstract][Full Text] [Related]
45. [Antiestrogens and normal human breast cell proliferation].
Mauvais-Jarvis P; Gompel A; Malet C; Kuttenn F
Ann Endocrinol (Paris); 1989; 50(3):181-8. PubMed ID: 2683973
[TBL] [Abstract][Full Text] [Related]
46. Classification and pharmacology of progestins.
Schindler AE; Campagnoli C; Druckmann R; Huber J; Pasqualini JR; Schweppe KW; Thijssen JH
Maturitas; 2003 Dec; 46 Suppl 1():S7-S16. PubMed ID: 14670641
[TBL] [Abstract][Full Text] [Related]
47. Steroid specificity in the stimulation of human endometrial estradiol dehydrogenase.
Tseng L
Endocrinology; 1978 May; 102(5):1398-1403. PubMed ID: 570483
[No Abstract] [Full Text] [Related]
48. Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer.
Aka JA; Mazumdar M; Lin SX
Mol Cell Endocrinol; 2009 Mar; 301(1-2):183-90. PubMed ID: 19038308
[TBL] [Abstract][Full Text] [Related]
49. Estradiol 17 beta-hydroxysteroid dehydrogenase activity in human breast fibroadenomas.
Fournier S; Kuttenn F; de Cicco F; Baudot N; Malet C; Mauvais-Jarvis P
J Clin Endocrinol Metab; 1982 Sep; 55(3):428-33. PubMed ID: 6954155
[TBL] [Abstract][Full Text] [Related]
50. Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer--II. A differential effect of megestrol acetate and medroxyprogesterone acetate on serum estrone sulfate and sex hormone binding globulin.
Lundgren S; Lønning PE
J Steroid Biochem; 1990 Jun; 36(1-2):105-9. PubMed ID: 2141886
[TBL] [Abstract][Full Text] [Related]
51. Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.
Hilborn E; Stål O; Jansson A
Oncotarget; 2017 May; 8(18):30552-30562. PubMed ID: 28430630
[TBL] [Abstract][Full Text] [Related]
52. Effect of progestins, estradiol, and coenzymes NAD and NADPH on the interconversion of estradiol and estrone in rabbit uterus in vitro.
Murugesan K; Vij U; Lal B; Farooq A
Steroids; 1989 Jun; 53(6):695-712. PubMed ID: 2554542
[TBL] [Abstract][Full Text] [Related]
53. Norelgestromin as selective estrogen enzyme modulator in human breast cancer cell lines. Effect on sulfatase activity in comparison to medroxyprogesterone acetate.
Pasqualini JR; Caubel P; Friedman AJ; Philippe JC; Chetrite GS
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):193-8. PubMed ID: 12711003
[TBL] [Abstract][Full Text] [Related]
54. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
Seeger H; Wallwiener D; Mueck AO
Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
[TBL] [Abstract][Full Text] [Related]
55. Estradiol as an anti-aromatase agent in human breast cancer cells.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2006 Jan; 98(1):12-7. PubMed ID: 16413774
[TBL] [Abstract][Full Text] [Related]
56. Relationship between estrogen receptors, 17 beta-hydroxysteroid dehydrogenase and estrogen content in human breast cancer.
Abul-Hajj YJ
Steroids; 1979 Aug; 34(2):217-25. PubMed ID: 494363
[TBL] [Abstract][Full Text] [Related]
57. Estrone sulfate: a potential source of estradiol in human breast cancer tissues.
Santner SJ; Leszczynski D; Wright C; Manni A; Feil PD; Santen RJ
Breast Cancer Res Treat; 1986; 7(1):35-44. PubMed ID: 3457610
[TBL] [Abstract][Full Text] [Related]
58. Modulation of lactogenic receptors by progestins in cultured human breast cancer cells.
Murphy LJ; Murphy LC; Stead B; Sutherland RL; Lazarus L
J Clin Endocrinol Metab; 1986 Feb; 62(2):280-7. PubMed ID: 3001123
[TBL] [Abstract][Full Text] [Related]
59. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway.
Santner SJ; Feil PD; Santen RJ
J Clin Endocrinol Metab; 1984 Jul; 59(1):29-33. PubMed ID: 6725522
[TBL] [Abstract][Full Text] [Related]
60. Effects on the breast of drugs used in fertility regulation.
Mauvais-Jarvis P
Hum Reprod; 1987 Feb; 2(2):159-62. PubMed ID: 3473070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
